The neurobiology of social phobia: from pharmacotherapy to brain imaging (Q31837126)

4 July 2017

1 reference

title

The neurobiology of social phobia: from pharmacotherapy to brain imaging (English)

1 reference

4 July 2017

0 references

0 references

Van Ameringen M

1

1 reference

4 July 2017

Mancini C

series ordinal

2

1 reference

4 July 2017

Farvolden P

series ordinal

3

1 reference

4 July 2017

Oakman J

series ordinal

4

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

Current Psychiatry Reports

4 July 2017

1 reference

4 July 2017

2

1 reference

4 July 2017

358-366

1 reference

4 July 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-000-0082-7

4 July 2017

0 references

cites work

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Social phobia. Comorbidity and morbidity in an epidemiologic sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Social phobia. Review of a neglected anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

The assessment and treatment of performance anxiety in musicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Specificity of lactate infusions in social phobia versus panic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Diagnostic and substance specificity of carbon-dioxide-induced panic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

The hypothalamic-pituitary-thyroid axis in social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Selective alteration of personality and social behavior by serotonergic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Lactic acid response to caffeine in panic disorder: comparison with social phobics and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Comparison of patients with panic disorder and social phobia and normal control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

21 January 2018

The shyness spectrum.

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Anxiety and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0082-7

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group

21 January 2018

1 reference

12 December 2020

Nefazodone for social phobia: a clinical case series

1 reference

12 December 2020

Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia.

1 reference

12 December 2020

Placebo-controlled trial of moclobemide in social phobia

1 reference

12 December 2020

Pharmacotherapy for social phobia: what works, what might work, and what does not work at all.

1 reference

12 December 2020

Magnetic resonance spectroscopy in social phobia: preliminary findings

1 reference

12 December 2020

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

12 December 2020

A predictive reinforcement model of dopamine neurons for learning approach behavior.

1 reference

12 December 2020

Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study

1 reference

12 December 2020

Effects of thyrotropin-releasing hormone on blood pressure and heart rate in phobic and panic patients: a pilot study

1 reference

12 December 2020

CSF 5-HIAA and aggression in female macaque monkeys: species and interindividual differences

1 reference

12 December 2020

Predictive reward signal of dopamine neurons

1 reference

12 December 2020

A brain single photon-emission computed tomography (SPECT) study of generalized social phobia

1 reference

12 December 2020

A computational role for dopamine delivery in human decision-making

1 reference

12 December 2020

Treatment of social phobia with gabapentin: a placebo-controlled study

1 reference

12 December 2020

Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study

1 reference

12 December 2020

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study

1 reference

12 December 2020

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

1 reference

12 December 2020

Peptides and psychiatry, Part 3: substance P and serendipity: novel psychotropics are a possibility

1 reference

12 December 2020

Venlafaxine in social phobia.

1 reference

12 December 2020

Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality.

1 reference

12 December 2020

Dominant social status facilitates the behavioral effects of serotonergic agonists.

1 reference

12 December 2020

Low dopamine D(2) receptor binding potential in social phobia

1 reference

12 December 2020

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor

1 reference

12 December 2020

Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers.

1 reference

12 December 2020

The 35% CO2 challenge test in patients with social phobia.

1 reference

12 December 2020

Autonomic responsivity in generalized social phobia

1 reference

12 December 2020

Serotonergic influences on the social behavior of vervet monkeys (Cercopithecus aethiops sabaeus)

1 reference

12 December 2020

fMRI reveals amygdala activation to human faces in social phobics

1 reference

12 December 2020

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

12 December 2020

Anxiety and growth disturbance: is there a connection? A review of biological studies in social phobia

1 reference

12 December 2020

Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders

1 reference

12 December 2020

5-HT and mechanisms of defence

1 reference

12 December 2020

CSF dopamine levels correlate with extraversion in depressed patients.

1 reference

12 December 2020

Treatment of social phobia with clonazepam and placebo.

1 reference

12 December 2020

Medication treatments for panic disorder and social phobia

1 reference

12 December 2020

A computational approach to prefrontal cortex, cognitive control and schizophrenia: recent developments and current challenges

1 reference

12 December 2020

Plasma and CSF HVA levels in panic patients with comorbid social phobia

1 reference

12 December 2020

Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine

1 reference

12 December 2020

Meta-analysis of cognitive-behavioral treatments for social phobia

1 reference

12 December 2020

Treatment of social phobia with clonidine

1 reference

12 December 2020

[3H]paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers

1 reference

12 December 2020

Treatment of social phobia with bupropion.

1 reference

12 December 2020

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

1 reference

12 December 2020

The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia. A double-blind, placebo-controlled clinical study

1 reference

12 December 2020

Hedonic valence, dopamine and motivation.

1 reference

12 December 2020

Abnormal shyness in children

1 reference

12 December 2020

Moclobemide in social phobia: a controlled dose-response trial

1 reference

12 December 2020

Harm avoidance and serotonin

1 reference

12 December 2020

The treatment of social phobia. Real-life rehearsal with nonprofessional therapists.

1 reference

12 December 2020

Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in rhesus macaque females

1 reference

12 December 2020

A repeat proton magnetic resonance spectroscopy study in social phobia.

1 reference

12 December 2020

Paroxetine in social anxiety disorder: a randomized placebo-controlled study

1 reference

12 December 2020

Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents

1 reference

12 December 2020

Corticotropin-releasing factor, norepinephrine, and stress

1 reference

12 December 2020

Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers

1 reference

12 December 2020

Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.

1 reference

12 December 2020

Nefazodone in social phobia

1 reference

12 December 2020

Levels of urinary free cortisol in social phobia

1 reference

12 December 2020

Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography.

1 reference

12 December 2020

Social phobia: a comparison of behavior therapy and atenolol

1 reference

12 December 2020

Flumazenil challenge in social phobia

1 reference

12 December 2020

Magnetic resonance imaging in social phobia.

1 reference

12 December 2020

The tachykinin NK1 receptor in the brain: pharmacology and putative functions

1 reference

12 December 2020

High-dose carbon dioxide challenge test in anxiety disorder patients

1 reference

12 December 2020

Dopamine reuptake site densities in patients with social phobia

1 reference

12 December 2020

10.1007/S11920-000-0082-7

Identifiers

DOI

1 reference

Dimensions Publication ID

4 July 2017

0 references

1 reference